Moritz Jesinghaus

3.3k total citations · 1 hit paper
92 papers, 2.0k citations indexed

About

Moritz Jesinghaus is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Moritz Jesinghaus has authored 92 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 27 papers in Surgery and 24 papers in Epidemiology. Recurrent topics in Moritz Jesinghaus's work include Neuroendocrine Tumor Research Advances (21 papers), Pancreatic and Hepatic Oncology Research (18 papers) and Genetic factors in colorectal cancer (16 papers). Moritz Jesinghaus is often cited by papers focused on Neuroendocrine Tumor Research Advances (21 papers), Pancreatic and Hepatic Oncology Research (18 papers) and Genetic factors in colorectal cancer (16 papers). Moritz Jesinghaus collaborates with scholars based in Germany, United States and Taiwan. Moritz Jesinghaus's co-authors include Wilko Weichert, Katja Steiger, Björn Konukiewitz, Nicole Pfarr, Melanie Boxberg, Günter Klöppel, Anna Melissa Schlitter, Albrecht Stenzinger, Andreas Kolk and Arne Warth and has published in prestigious journals such as Nature Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Moritz Jesinghaus

87 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer

2023 141 citations Sebastian Foersch, Markus Eckstein et al. profile →

Peers

Countries citing papers authored by Moritz Jesinghaus

Since Specialization

Citations

This map shows the geographic impact of Moritz Jesinghaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moritz Jesinghaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moritz Jesinghaus more than expected).

Fields of papers citing papers by Moritz Jesinghaus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moritz Jesinghaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moritz Jesinghaus. The network helps show where Moritz Jesinghaus may publish in the future.

Co-authorship network of co-authors of Moritz Jesinghaus

This figure shows the co-authorship network connecting the top 25 collaborators of Moritz Jesinghaus. A scholar is included among the top collaborators of Moritz Jesinghaus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moritz Jesinghaus. Moritz Jesinghaus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Retrospective analysis of criteria for oncological completion surgery of neuroendocrine tumors of the appendix 2025 ·Langenbeck s Archives of Surgery ·Sabine Wächter, Dimitrios Panidis, Moritz Jesinghaus, Anja Rinke, Monika Heinzel‐Gutenbrunner, Elisabeth Maurer, Detlef K. Bartsch	1
2	Incidental Prompt Injections on Vision–Language Models in Real-Life Histopathology 2025 ·NEJM AI ·Jan Clusmann, Stefan Schulz, Dyke Ferber, Isabella C. Wiest, Aurélie Fernandez, Markus Eckstein, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Carolin V. Schneider, Daniel Truhn, Wilfried Roth, Moritz Jesinghaus, Jakob Nikolas Kather, Sebastian Foersch	3
3	Morphological subtypes of colorectal low-grade intraepithelial neoplasia: diagnostic reproducibility, frequency and clinical impact 2023 ·Journal of Clinical Pathology ·Corinna Lang‐Schwarz, Maike Büttner‐Herold, (unknown), Ramona Erber, Arndt Hartmann, Moritz Jesinghaus, Kateřina Kamarádová, (unknown), Gerhard Seitz, William Sterlacci, Michael Vieth, Simone Bertz	10
4	High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma 2023 ·Journal of Ovarian Research ·Paul Jank, Jonas Leichsenring, (unknown), Inga Hoffmann, Philip Bischoff, Catarina Alisa Kunze, Mihnea P. Dragomir, (unknown), Moritz Jesinghaus, Wolfgang Schmitt, Hagen Kulbe, Christine Sers, Albrecht Stenzinger, Jalid Sehouli, Elena Ioana Braicu, (unknown), David Horst, Carsten Denkert, Stefan Gröschel, Eliane T. Taube	5
5	Independent Tissue-Based Biomarkers in Endometrioid Endometrial Cancer: Tumor Budding in Microsatellite Instability and WHO Grading in Copy-Number-Low Patients 2023 ·Cancers ·Fabian Stögbauer, (unknown), Christine Brambs, (unknown), Tim Kacprowski, (unknown), Holger Bronger, Marion Kiechle, Aurelia Noske, Gisela Keller, Moritz Jesinghaus, Christopher Poremba, Wilko Weichert, Melanie Boxberg	1
6	Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19 2022 ·Gut Microbes ·David Schult, Sandra Reitmeier, (unknown), Tobias Lahmer, Moritz Middelhoff, Johanna Erber, Jochen Schneider, (unknown), (unknown), Julia Horstmann, (unknown), Katja Steiger, Moritz Jesinghaus, Klaus‐Peter Janssen, Ulrike Protzer, Klaus Neuhaus, Roland M. Schmid, Dirk Haller, Michael Quante	59
7	SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis 2022 ·Cancer Research ·(unknown), Markus Tschurtschenthaler, Matjaž Rokavec, Miguel G. Silva, Moritz Jesinghaus, Thomas Kirchner, Frederick Klauschen, Dieter Saur, Jens Neumann, Heiko Hermeking, Peter Jung	19
8	Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk Subgroups 2021 ·Cancers ·(unknown), Miguel G. Silva, Björn Konukiewitz, (unknown), Katja Steiger, Kathrin Halfter, Jutta Engel, Paul Jank, Nicole Pfarr, Dirk Wilhelm, Sebastian Foersch, Carsten Denkert, Markus Tschurtschenthaler, Wilko Weichert, Moritz Jesinghaus	13
9	PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer 2021 ·JCI Insight ·(unknown), Sebastian Lange, H. Carlo Maurer, Kenneth P. Olive, Rickmer Braren, Nicole Pfarr, (unknown), Alexander Muckenhuber, Moritz Jesinghaus, Katja Steiger, Wilko Weichert, Helmut Friess, Roland M. Schmid, Hana Algül, Philipp J. Jost, Juliane Ramser, Christine Fischer, Anne S. Quante, Maximilian Reichert, Michael Quante	7
10	Loss of CDX2 in colorectal cancer is associated with histopathologic subtypes and microsatellite instability but is prognostically inferior to hematoxylin–eosin-based morphologic parameters from the WHO classification 2021 ·British Journal of Cancer ·Björn Konukiewitz, (unknown), Miguel G. Silva, (unknown), (unknown), Katja Steiger, Kathrin Halfter, Jutta Engel, Anna Melissa Schlitter, Melanie Boxberg, Nicole Pfarr, Dirk Wilhelm, Sebastian Foersch, Markus Tschurtschenthaler, Wilko Weichert, Moritz Jesinghaus	22
11	Diverse ‘just-right’ levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer 2021 ·British Journal of Cancer ·(unknown), (unknown), Bianca Grosser, Nicole Pfarr, Moritz Jesinghaus, Julia Slotta‐Huspenina, Alexander Novotny, Alexander Hapfelmeier, Thomas Schmidt, Katja Steiger, Matthias M. Gaida, (unknown), (unknown), Katja Ott, Wilko Weichert, Gisela Keller	12
12	Pre-operative cellular dissociation grading in biopsies is highly predictive of post-operative tumour stage and patient outcome in head and neck squamous cell carcinoma 2020 ·British Journal of Cancer ·Moritz Jesinghaus, Katja Steiger, Fabian Stögbauer, Bernhard Haller, Andreas Kolk, Ulrich Straßen, Anja Pickhard, Markus Wirth, Miguel G. Silva, Jan Budczies, (unknown), Björn Konukiewitz, (unknown), Konrad Klinghammer, Hendrik Dapper, Stefan Münch, Stephanie E. Combs, Wilko Weichert, Melanie Boxberg	13
13	Composition and Clinical Impact of the Immunologic Tumor Microenvironment in Oral Squamous Cell Carcinoma 2018 ·The Journal of Immunology ·Melanie Boxberg, (unknown), Katja Steiger, Moritz Jesinghaus, (unknown), (unknown), Nicole Pfarr, Carolin Götz, Klaus Wolff, Wilko Weichert, Andreas Kolk	70
14	Pitfalls in Ga-68-PSMA-PET/CT: incidental finding of parathyroid adenoma 2018 ·European Journal of Nuclear Medicine and Molecular Imaging ·Christian H. Pfob, (unknown), Moritz Jesinghaus, Alexander Novotny, Wolfgang Weber, Matthias Eiber, Benedikt Feuerecker	10
15	Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3 2018 ·Human Pathology ·Björn Konukiewitz, Moritz Jesinghaus, Katja Steiger, Anna Melissa Schlitter, Atsuko Kasajima, Bence Sipos, Giuseppe Zamboni, Wilko Weichert, Nicole Pfarr, Günter Klöppel	81
16	Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response 2017 ·Clinical Cancer Research ·Alexander Muckenhuber, Anne Berger, Anna Melissa Schlitter, Katja Steiger, Björn Konukiewitz, Andreas Trumpp, Roland Eils, Jens Werner, Helmut Friess, Iréne Esposito, Günter Klöppel, Güralp O. Ceyhan, Moritz Jesinghaus, Carsten Denkert, Marcus Bahra, Albrecht Stenzinger, Martin R. Sprick, Dirk Jäger, Christoph Springfeld, Wilko Weichert	61
17	CXCR4 Is a Potential Target for Diagnostic PET/CT Imaging in Barrett's Dysplasia and Esophageal Adenocarcinoma 2017 ·Clinical Cancer Research ·Hsin‐Yu Fang, (unknown), Margret Schottelius, (unknown), Haibo Liu, Michael Schauer, Stefan Stangl, Gabriele Multhoff, Katja Steiger, Carlos Gerngroß, Moritz Jesinghaus, Wilko Weichert, Anja A. Kühl, Antonia R. Sepulveda, Hans‐Jürgen Wester, Timothy C. Wang, Michael Quante	35
18	Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology 2017 ·Genes Chromosomes and Cancer ·Nicole Pfarr, Silvia Darb‐Esfahani, Jonas Leichsenring, Eliane T. Taube, Melanie Boxberg, Elena Ioana Braicu, Moritz Jesinghaus, Roland Penzel, Volker Endris, Aurelia Noske, Wilko Weichert, Peter Schirmacher, Carsten Denkert, Albrecht Stenzinger	16
19	A novel pretherapeutic gene expression-based risk score for treatment guidance in gastric cancer 2017 ·Annals of Oncology ·(unknown), Alexander Hapfelmeier, Susanne Blank, (unknown), Julia Slotta‐Huspenina, Moritz Jesinghaus, Alexander Novotny, Thomas Schmidt, Bianca Grosser, (unknown), Wilko Weichert, Katja Ott, Gisela Keller	13
20	Profiling of cMET and HER Family Receptor Expression in Pancreatic Ductal Adenocarcinomas and Corresponding Lymph Node Metastasis to Assess Relevant Pathways for Targeted Therapies 2016 ·Pancreas ·Alexander Muckenhuber, (unknown), Marlène Thomas, Gabriele Hölzlwimmer, M Zając, Moritz Jesinghaus, Frank Bergmann, Jens Werner, Albrecht Stenzinger, Wilko Weichert	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact